Leading In Product Development Means Planning For All Eventualities
Using Failure Investigation Data Earlier In Product Development
What is the cost of an adverse event, and the resulting safety action for a medical device that is already on the market? It is the kind of question that no company with products on the market wants to have to confront, but it is also one they know they should plan for, says the design consultancy and innovation organization NCS Lab srl.
You may also be interested in...
ABHI’s Phil Brown looks beyond the immediate challenges for UK medtechs on being outside the EU, and to an innovation-friendly, patient-responsive system of future regulation.
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.